Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Clinical Kidney Journal|December 21, 2016
Macrophage in chronic kidney diseaseRoser Guiteras, Maria Flaquer, Josep M Cruzado
Current Opinion in Organ Transplantation|February 22, 2013
Kidney regeneration and repair after transplantationMarcella Franquesa, Maria Flaquer, Josep M Cruzado, et al.
Journal of Cellular and Molecular Medicine|November 9, 2018
Exploring macrophage cell therapy on Diabetic Kidney DiseaseRoser Guiteras, Anna Sola, Maria Flaquer, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 10, 2017
Macrophage Overexpressing NGAL Ameliorated Kidney Fibrosis in the UUO Mice ModelRoser Guiteras, Anna Sola, Maria Flaquer, et al.
Diabetes, Obesity & Metabolism|February 18, 2026
Effect of lixisenatide on arterial stiffness in people with type 2 diabetes and kidney disease: Results of a randomised controlled trialNikolaos Fountoulakis, Panagiotis Pavlou, Dimitra Stathi, et al.
British Journal of Clinical Pharmacology|August 9, 2022
Effect of calcitriol treatment on arterial stiffness in people with type 2 diabetes and stage 3 chronic kidney diseaseJanaka Karalliedde, Nikolaos Fountoulakis, Antonella Corcillo, et al.
Life Sciences|July 6, 2010
The combination of sirolimus and rosiglitazone produces a renoprotective effect on diabetic kidney disease in ratsMaria Flaquer, Núria Lloberas, Marcella Franquesa, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 13, 2009
Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage?Juan Torras, Immaculada Herrero-Fresneda, Oscar Gulias, et al.
Pageof 2